LENSAR INC (LNSR) Stock Price, Forecast & Analysis
USA - NASDAQ:LNSR - US52634L1089 - Common Stock
LNSR Key Statistics, Chart & Performance
The current stock price of LNSR is 10.04 USD. In the past month the price decreased by -17.84%. In the past year, price increased by 36.04%.
LNSR Latest News, Press Relases and Analysis
LNSR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.28 | 219.56B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.58 | 202.41B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.88 | 143.74B | ||
| SYK | STRYKER CORP | 27.66 | 139.25B | ||
| IDXX | IDEXX LABORATORIES INC | 55.28 | 55.77B | ||
| BDX | BECTON DICKINSON AND CO | 13.26 | 54.81B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.47 | 50.50B | ||
| RMD | RESMED INC | 24.75 | 35.75B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.75 | 33.01B | ||
| PODD | INSULET CORP | 75.79 | 24.38B | ||
| DXCM | DEXCOM INC | 32.11 | 23.42B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.06 | 17.72B |
Related stock screener links
About LNSR
Company Profile
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 140 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The firm has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
Company Info
LENSAR INC
2800 Discovery Drive, Suite 100
Orlando FLORIDA 32826 US
CEO: Nicholas Curtis
Employees: 140
Phone: 18885367271
LENSAR INC / LNSR FAQ
What does LENSAR INC do?
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 140 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The firm has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
What is the current price of LNSR stock?
The current stock price of LNSR is 10.04 USD. The price increased by 0.7% in the last trading session.
Does LENSAR INC pay dividends?
LNSR does not pay a dividend.
How is the ChartMill rating for LENSAR INC?
LNSR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists LNSR stock?
LNSR stock is listed on the Nasdaq exchange.
Is LENSAR INC (LNSR) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LNSR.
What is the outstanding short interest for LENSAR INC?
The outstanding short interest for LENSAR INC (LNSR) is 5.83% of its float.
LNSR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to LNSR. When comparing the yearly performance of all stocks, LNSR is one of the better performing stocks in the market, outperforming 73.13% of all stocks.
LNSR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LNSR. LNSR has a bad profitability rating. Also its financial health evaluation is rather negative.
LNSR Financial Highlights
Over the last trailing twelve months LNSR reported a non-GAAP Earnings per Share(EPS) of -4.39. The EPS decreased by -200.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -70.03% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
LNSR Forecast & Estimates
7 analysts have analysed LNSR and the average price target is 15.3 USD. This implies a price increase of 52.39% is expected in the next year compared to the current price of 10.04.
For the next year, analysts expect an EPS growth of 89.88% and a revenue growth 32.69% for LNSR